https://orcid.org/0000-0002-5270-9834
References
- Devay AO, Gomceli I, Korukluoglu B, et al. An unusual and difficult diagnosis of intestinal obstruction: the abdominal cocoon. Case report and review of the literature. World J Emerg Surg. 2006;1(1):8.
- Allam H, Al Yahri O, Mathew S, et al. The enigma of primary and secondary encapsulating peritoneal sclerosis. BMC Surg. 2016;16(1):81.
- Akbulut S. Accurate definition and management of idiopathic sclerosing encapsulating peritonitis. World J Gastroenterol. 2015;21(2):675–687.
- Ryckelynck J-P, Béchade C, Bouvier N, et al. [Encapsulating peritoneal sclerosis]. Nephrol Ther. 2017;13(4):211–219.
- Loureiro J, Sandoval P, del Peso G, et al. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. PLoS One. 2013;8(4):e61165.
- Christou N, Perraud A, Blondy S, et al. E-cadherin: a potential biomarker of colorectal cancer prognosis). Oncol Lett. 2017;13(6):4571–4576.
- Wilson RB. Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis. Pleura Peritoneum. 2018;3(1):20180103.